Recombinant erythropoietin increases blood pressure in experimental hypertension and uraemia without change in vascular cytosolic calcium

Nephron

Volumn 73, Issue 2, 1996, Pages 212-218

  Roger, Simon D ^a   Fitick, Richard J ^a   Mc Mahon, Aisling C ^a   Raine, Anthony E G ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Cytosolic calcium; Erythropoietin; Hypertension; Uraemia

Indexed keywords

ANTIANEMIC AGENT; CREATININE; FURA 2; HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; BLOOD PRESSURE; CALCIUM CELL LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIALYSIS; HYPERTENSION; KIDNEY FUNCTION; MALE; NONHUMAN; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SUBCUTANEOUS DRUG ADMINISTRATION; UREA BLOOD LEVEL; UREMIA; VASCULAR SMOOTH MUSCLE;

ANALYSIS OF VARIANCE; ANIMALS; AORTA, THORACIC; BLOOD PRESSURE; CALCIUM; CREATININE; CYTOSOL; ERYTHROPOIETIN, RECOMBINANT; HEMOGLOBINS; HYPERTENSION; MALE; MUSCLE, SMOOTH, VASCULAR; NEPHRECTOMY; RATS; RATS, INBRED SHR; RATS, INBRED WKY; UREA; UREMIA;

EID: 0029980087     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189043     Document Type: Article

References (45)

1. Raine AEG: Hypertension, blood viscosity and cardiovascular morbidity in renal failure: Implications for erythropoietin therapy. Lancet 1988;i:97-100.
2. Rame AEG. Roger SD: Effects of erythropoietin on blood pressure. Am J Kidney Dis 1991: 18(suppl 1):76-83.
3. Ludwig II. Fritz E. Kotzmann H. Hocker P. Gisslingcr H. Bamas U: Erythropoietin treatment of anemia associated with multiple myeloma. N Engl J Med 1990;322:1693-1699.
4. Fischl M, Galpin IE. Levine JD. et al: Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med 1990;322:1488-1493.
5. Pincus T. Olsen NJ. Russell J. et al: Multiccn-ter study of recombinant human erythropoietin in correction of anaemia in rheumatoid arthritis. Am J Med 1990:89:161-168.
6. Samtleben W, Baldamus CA. Bommer J. Fassbinder W. Nonnast-Daniel B. Gurland HJ: Blood pressure changes during treatment with recombinant human erythropoietin. Contrib Nephrol. Basel. Karger. 1988. vol 66. pp 114-122.
7. Sundal E. Kaescr U: Correction of anaemia of chronic renal failure with recombinant human erythropoietin: Safety and efficacy of one year's treatment in a European mullicentrc study of 150 haemodialysis-dependent patients. Nephrol Dial Transplant 1989:4:979-987.
8. Casati S, Passerini P. Campise MR. Graziani G. Casana B. Perisic M. Ponticelli C: Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialvsis. Br Med J 1987:295:1017-1020.
9. Buckner FF. Eschbach JW. Haley NR. Davidson RR. Adamson JW: Correction of the anaemia in haemodialysis patients with recombinant human erythropoietin: Haemodynamic changes and risks for hypertension. Kidney Int 1989,35:190.
10. Satoh K. Masuda T, Ikeda Y. el al: Hemodynamic changes by recombinant erythropoietin therapy in hemodialyzed patients. Hypertension 1990:15:262-266.
11. London GM. Zins B. Pannier B. Narel C, Bcr-thelot J-M, Jacquot C. Safar M. Drueke TB: Vascular changes in hemodialysis patients in response to recombinant human erythropoietin. Kidney Int 1989;36:878-882.
12. Deschodl G. Granollcras C, Alsabadani B. et al: Changes in cardiac output, blood pressure and peripheral resistance following treatment of renal anaemia by recombinant human erythropoietin. Nephrol Dial Transplant 1988:3: 494-495.
13. Nonnast-Daniel D. Frei U. Brabant EG, Ta-lartschik J. Schaeffer J. Daniel WG, Koch KM: Atrial natriuretic peptide and central haemo-dynamics during correction of renal anaemia by recombinant human erythropoietin treatment in regular dialysis treatment patients. Nephrol Dial Transplant 1989;4:478.
14. Heidenreich S. Rahn KH. Zidck W: Erythropoietin induces contraction of isolated renal small resistance vessels. Nephrol Dial Transplant 1990:5:739-740.
15. Jamgotchian N. Krall JF, Hu MS. Abdella P. Lee DBN: An animal model for recombinant human erythropoietin-induced hypertension. Kidney Int 1990:37:387.
16. Bund SJ, Heagerty A, Edmunds M, Walls J: Erythropoietin docs not induce vasoconstriction directly in human subcutaneous resistance arterioles. Nephron 1989:53:173.
17. Van Geet C, van Dammc-Lombacrts R. Van-russelt M. de Mol A. Proesmans W. Verntylen J: Recombinant human erythropoietin increases blood pressure, platelet aggregability and platelet free calcium mobilisation in uraemic children: A possible link? Thromb Haemost 1990:64:7-10.
18. Okamoto K. Aoki K: Development of a strain of spontaneously hypertensive rats. Jpn Circ J 1963:27:282-293.
19. Udenfriend S, Spector S: Spontaneously hypertensive rat. Science 1972:176:1155-1156.
20. Chanutin A. Ferris EB: Experimental renal insufficiency produced by partial nephrectomy. 1. Control diet. Arch Intern Med 1932:49:767-787.
21. Pfeffer JM. Pfeffer MA. Fröhlich ED: Validity of an indirect lail-cufif method for determining systolic arterial pressure in unanacsthetised normotensive and spontaneously hypertensive rats. J Lab Clin Med 1971:78:957-962.
22. Grainger DJ. Hesketh TR. Metcalfe JC. Weiss-bcrg PL: A large accumulation of non-muscle myosin occurs at first entry into M-phase in rat VSMC. Biochem J 1991:277:145-151.
23. Grynkiewicz G, Pocnie M. Tsien RY: A new generation of Ca:* indicators with greatly improved fluorescence properties. J Biol Chern 1985:260:3440-3450.
24. Erne P. Bolli P. Biirgisser E. Biihler FR: Correlation of platelet calcium with blood pressure: Effect of antihypertensive therapy. N Engl J Med 1984;310:1084-1088.
25. Bruschi G. Bruschi ME. Caroppo M. Oriandini G. Spaggiari M. Cavatorta A: Cytoplasmic calcium is increased in spontaneously hypertensive rats and essential hypertensive patients. Clin Sei 1985;68:179-184.
26. Hinssen H. D'Haese J. Small JV, Sobicszck EK: Mode of filament assembly of myosins from muscle and non-musclc cells. J Ultra-struct Res 1978:64:282-302.
27. Niederman R. Pollard TD: Human platelet myosin. 11. In vitro assembly and structure of myosin filaments. J Cell Biol 1975:67:72-92.
28. Ueno H. Mikawa M. Takata M. Asanoi H. lida H. Sasayama S. Kagamimori S: Does cytosolic free calcium concentration in platelets reflect tone and structural changes in resistance vessels? J Hypcrtcns 1988:6(suppl 4):S255-S257.
29. Mulvany MJ: Pathophysiology of vascular smooth muscle in hypertension. J Hypertens 1984;2(suppl 4):S413-S420.
30. Bohr DF. Webb RC: Vacular smooth muscle function and its changes in hypertension. Am J Med 1985:77:3-16.
31. Mulvany MJ: Do resistance vessel abnormalities contribute to the elevated blood pressure of spontaneously hypertensive rats? Blood Vessels 1983;20:1-22.
32. Garcia DL, Anderson S, Rennke HG. Brenner BM: Anemia lessons and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass. Proc Natl Acad Sei USA 1988:85:6142-6146.
33. Lafferty HM. Anderson S. Brenner BM: Anemia: A potent modulator of renal hemodynamics in models of progressive renal disease. Am J Kidney Dis 1991:17(suppl l):2-7.
34. Canadian Erythropoietin Study Group: Effect of recombinant human erythropoietin therapy on blood pressure in hemodialysis patients. Am J Nephrol 1991;11:23-26.
35. Muntzcl M, Hannedouche T, Lacour B. Drucke TB: Erythropoietin increases blood pressure in normotensive and hypertensive rats. Nephron 1993:65:601-604.
36. Nabika T. Vellctri PA. Beaven MA. Endo J. LovenbergW: Vasopressin induced calcium increases in smooth muscle cells from spontaneously hypertensive rats. Life Sei 1985:37: 579-584.
37. Sugivama T. Yoshizumi M, Takaku F. Yazaki Y: Abnormal calcium handling in vascular smooth muscle cells of spontaneously hypertensive rats. J Hypertens 1990:8:369-375.
38. Sada T. Koike M. Sato K. Ozaki H. Karaki H: Cytosolic free calcium of aorta in hypertensive rats. Hypertension 1990:16:245-251.
39. Tepel M. Wischniowski H. Zidck W: Erythropoietin increases cytosolic free calcium concentration and thrombin-induced changes in cytosolic free calcium in platelets from spontaneously hypertensive rats. Biochem Biophys ResCommun 1991:177:991-997.
40. Worthington RE: Calcium response to erythropoietin in erythroleukaemic cells. Exp Cell Res 1989:184:250-255.
41. Miller BA. Scaduto RC. Tillotson DL. Botti JJ. Cheung JY: Erythropoietin stimulates a rise in intracellular free calcium concentration in single early human erythroid precursors. J Clin Invest 1988:82:309-315.
42. Anagnostou A. Lee ES, Kessiman N. Levinson R: Erythropoietin has a mitogenic and positive chcmotaclic effect on endothelial cells. Proc Natl Acad Sei USA 1990:87:5978-5982.
43. Carlini RG. Obialo CI. Rothstcin M: Intravenous erythropoietin (r-HuEPO) administration increases plasma endothclin and blood pressure in hemodialysis patients. Am J Hypertens 1993:6:103-107.
44. Carlini RG, Dusso AS, Obialo CL Alvarez UM. Rothstein M: Recombinant human erythropoietin increases endothclin-1 release by endothelial cells. Kidney Int 1993:43:1010-1014
45. Gogusev J. Zhu D-L. Hercmbcrt T. Ammar-guellat F. Marche P. Drucke TB: Effect of erythropoietin on DNA synthesis, proto-onco-gcnc expression and phospholipase C activity in ra: vascular smooth muscle cells. Biochem Biophys ResCommun 1994:199:977-983.